Showing results (1-10 of 6,094) with videos related to
Sort By:
Pageof 610
Cancer Cell|March 16, 2010
IDH1 and IDH2: not your typical oncogenesZachary J Reitman, D Williams Parsons, Hai YanJournal of the National Cancer Institute|June 2, 2010
Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolismZachary J Reitman, Hai YanCancer Cell|May 18, 2013
Releasing the block: setting differentiation free with mutant IDH inhibitorsChristopher J Pirozzi, Zachary J Reitman, Hai YanBlood|November 16, 2014
Genetic dissection of leukemia-associated IDH1 and IDH2 mutants and D-2-hydroxyglutarate in DrosophilaZachary J Reitman, Sergey A Sinenko, Eric P Spana, et al.European Journal of Medicinal Chemistry|May 11, 2016
Radiolabeled inhibitors as probes for imaging mutant IDH1 expression in gliomas: Synthesis and preliminary evaluation of labeled butyl-phenyl sulfonamide analogsSatish K Chitneni, Zachary J Reitman, David M Gooden, et al.Cancer Research|December 10, 2009
Mutant metabolic enzymes are at the origin of gliomasHai Yan, Darell D Bigner, Victor Velculescu, et al.Nature Chemical Biology|September 25, 2012
Enzyme redesign guided by cancer-derived IDH1 mutationsZachary J Reitman, Bryan D Choi, Ivan Spasojevic, et al.Bioorganic & Medicinal Chemistry Letters|January 26, 2018
Synthesis and evaluation of radiolabeled AGI-5198 analogues as candidate radiotracers for imaging mutant IDH1 expression in tumorsSatish K Chitneni, Zachary J Reitman, Rebecca Spicehandler, et al.Plos One|February 18, 2011
2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutationsGenglin Jin, Zachary J Reitman, Ivan Spasojevic, et al.Seminars in Neurology|March 17, 2018
New Directions in the Treatment of GlioblastomaZachary J Reitman, Frank Winkler, Andrew E H EliaPageof 610